Furthermore, we show that MAGI2-AS3 and HOXB7 can serve as biomarkers for radio-resistance and that gene therapy through MAGI2-AS3 restoration or HOXB7 silencing may improve the treatment of esophageal cancer by overcoming radioresistance. The gene discussed is HOXB7; the disease is esophageal cancer.